Literature DB >> 31552380

Active Disclosure of Secondary Germline Findings to Deceased Research Participants' Personal Representatives: Process and Outcomes.

Molly Daniels1, Chetna Wathoo2, Lauren Brusco2, Karen H Lu3, Kenna Shaw2, Ecaterina E Ileana Dumbrava4, Banu Arun5, Louise Strong6, Jennifer K Litton5, Karina Eterovic7, Ugur Aytac2, John Mendelsohn2,8, Gordon B Mills2,7, Ken Chen9, Funda Meric-Bernstam2,4.   

Abstract

Entities:  

Year:  2017        PMID: 31552380      PMCID: PMC6759057          DOI: 10.1200/po.17.00074

Source DB:  PubMed          Journal:  JCO Precis Oncol        ISSN: 2473-4284


× No keyword cloud information.
  8 in total

1.  Returning a Research Participant's Genomic Results to Relatives: Analysis and Recommendations.

Authors:  Susan M Wolf; Rebecca Branum; Barbara A Koenig; Gloria M Petersen; Susan A Berry; Laura M Beskow; Mary B Daly; Conrad V Fernandez; Robert C Green; Bonnie S LeRoy; Noralane M Lindor; P Pearl O'Rourke; Carmen Radecki Breitkopf; Mark A Rothstein; Brian Van Ness; Benjamin S Wilfond
Journal:  J Law Med Ethics       Date:  2015       Impact factor: 1.718

2.  Genomic inheritances: disclosing individual research results from whole-exome sequencing to deceased participants' relatives.

Authors:  Ben Chan; Flavia M Facio; Haley Eidem; Sara Chandros Hull; Leslie G Biesecker; Benjamin E Berkman
Journal:  Am J Bioeth       Date:  2012       Impact factor: 11.229

3.  Incidental germline variants in 1000 advanced cancers on a prospective somatic genomic profiling protocol.

Authors:  F Meric-Bernstam; L Brusco; M Daniels; C Wathoo; A M Bailey; L Strong; K Shaw; K Lu; Y Qi; H Zhao; H Lara-Guerra; J Litton; B Arun; A K Eterovic; U Aytac; M Routbort; V Subbiah; F Janku; M A Davies; S Kopetz; J Mendelsohn; G B Mills; K Chen
Journal:  Ann Oncol       Date:  2016-01-19       Impact factor: 32.976

4.  Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence.

Authors:  Giulio Genovese; Anna K Kähler; Robert E Handsaker; Johan Lindberg; Samuel A Rose; Samuel F Bakhoum; Kimberly Chambert; Eran Mick; Benjamin M Neale; Menachem Fromer; Shaun M Purcell; Oscar Svantesson; Mikael Landén; Martin Höglund; Sören Lehmann; Stacey B Gabriel; Jennifer L Moran; Eric S Lander; Patrick F Sullivan; Pamela Sklar; Henrik Grönberg; Christina M Hultman; Steven A McCarroll
Journal:  N Engl J Med       Date:  2014-11-26       Impact factor: 91.245

5.  American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility.

Authors:  Mark E Robson; Angela R Bradbury; Banu Arun; Susan M Domchek; James M Ford; Heather L Hampel; Stephen M Lipkin; Sapna Syngal; Dana S Wollins; Noralane M Lindor
Journal:  J Clin Oncol       Date:  2015-08-31       Impact factor: 44.544

6.  Attitudes toward molecular testing for personalized cancer therapy.

Authors:  Rafeek A Yusuf; Deevakar Rogith; Shelly R A Hovick; Susan K Peterson; Allison M Burton-Chase; Bryan M Fellman; Yisheng Li; Carolyn McKinney; Elmer V Bernstam; Funda Meric-Bernstam
Journal:  Cancer       Date:  2014-09-10       Impact factor: 6.860

7.  Illustrative case studies in the return of exome and genome sequencing results.

Authors:  Laura M Amendola; Denise Lautenbach; Sarah Scollon; Barbara Bernhardt; Sawona Biswas; Kelly East; Jessica Everett; Marian J Gilmore; Patricia Himes; Victoria M Raymond; Julia Wynn; Ragan Hart; Gail P Jarvik
Journal:  Per Med       Date:  2015       Impact factor: 2.512

8.  ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.

Authors:  Robert C Green; Jonathan S Berg; Wayne W Grody; Sarah S Kalia; Bruce R Korf; Christa L Martin; Amy L McGuire; Robert L Nussbaum; Julianne M O'Daniel; Kelly E Ormond; Heidi L Rehm; Michael S Watson; Marc S Williams; Leslie G Biesecker
Journal:  Genet Med       Date:  2013-06-20       Impact factor: 8.822

  8 in total
  1 in total

1.  Expanded analysis of secondary germline findings from matched tumor/normal sequencing identifies additional clinically significant mutations.

Authors:  E Ileana Dumbrava; L Brusco; M Daniels; C Wathoo; K Shaw; K Lu; X Zheng; L Strong; J Litton; B Arun; A K Eterovic; M Routbort; K Patel; Yuan Qi; S Piha-Paul; V Subbiah; D Hong; J Rodon; S Kopetz; J Mendelsohn; G B Mills; K Chen; F Meric-Bernstam
Journal:  JCO Precis Oncol       Date:  2019-04-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.